160 related articles for article (PubMed ID: 31152640)
1. Importance of 6-Thioguanine Nucleotide Metabolite Monitoring in Inflammatory Bowel Disease Patients Treated with Azathioprine.
Pavlovska K; Petrushevska M; Gjorgjievska K; Zendelovska D; Ribarska JT; Kikerkov I; Gjatovska LL; Atanasovska E
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):73-79. PubMed ID: 31152640
[TBL] [Abstract][Full Text] [Related]
2. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B
Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
[TBL] [Abstract][Full Text] [Related]
3. Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.
Lee MN; Kang B; Choi SY; Kim MJ; Woo SY; Kim JW; Choe YH; Lee SY
Inflamm Bowel Dis; 2015 May; 21(5):1054-62. PubMed ID: 25851563
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
[TBL] [Abstract][Full Text] [Related]
5. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients.
Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N
Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547
[TBL] [Abstract][Full Text] [Related]
6. Adjustment of azathioprine dose should be based on a lower 6-TGN target level to avoid leucopenia in NUDT15 intermediate metabolisers.
Kang B; Kim TJ; Choi J; Baek SY; Ahn S; Choi R; Lee SY; Choe YH
Aliment Pharmacol Ther; 2020 Aug; 52(3):459-470. PubMed ID: 32598049
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
Armstrong L; Sharif JA; Galloway P; McGrogan P; Bishop J; Russell RK
Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
Jharap B; de Boer NK; Stokkers P; Hommes DW; Oldenburg B; Dijkstra G; van der Woude CJ; de Jong DJ; Mulder CJ; van Elburg RM; van Bodegraven AA;
Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis.
Wusk B; Kullak-Ublick GA; Rammert C; von Eckardstein A; Fried M; Rentsch KM
Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1407-13. PubMed ID: 15618853
[TBL] [Abstract][Full Text] [Related]
10. Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease.
Vikingsson S; Andersson D; Almer S; Peterson C; Hindorf U
J Crohns Colitis; 2014 Dec; 8(12):1702-9. PubMed ID: 25239576
[TBL] [Abstract][Full Text] [Related]
11. Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease.
Ohtsuka Y; Arai K; Aoyagi Y; Fujii T; Yamakawa Y; Ohtani K; Ikuse T; Baba Y; Inage E; Kudo T; Suzuki R; Nagata S; Shimizu T
J Gastroenterol Hepatol; 2010 Oct; 25(10):1626-30. PubMed ID: 20880170
[TBL] [Abstract][Full Text] [Related]
12. 6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's Disease.
Mao R; Guo J; Luber R; Chen BL; He Y; Zeng ZR; Ben-Horin S; Sparrow MP; Roblin X; Chen MH
Inflamm Bowel Dis; 2018 Nov; 24(12):2621-2627. PubMed ID: 29788262
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
Thomas CW; Lowry PW; Franklin CL; Weaver AL; Myhre GM; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
Inflamm Bowel Dis; 2003 Jul; 9(4):237-45. PubMed ID: 12902847
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
[TBL] [Abstract][Full Text] [Related]
15. Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease.
Pozler O; Chládek J; Malý J; Hroch M; Dědek P; Beránek M; Krásničanová P
J Crohns Colitis; 2010 Dec; 4(6):623-8. PubMed ID: 21122571
[TBL] [Abstract][Full Text] [Related]
16. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
Angelberger S; Schaeffeler E; Teml A; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR; Schwab M; Reinisch W
Inflamm Bowel Dis; 2013 Mar; 19(3):590-8. PubMed ID: 23388543
[TBL] [Abstract][Full Text] [Related]
17. Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations.
Curkovic I; Rentsch KM; Frei P; Fried M; Rogler G; Kullak-Ublick GA; Jetter A
Eur J Clin Pharmacol; 2013 Aug; 69(8):1521-31. PubMed ID: 23588559
[TBL] [Abstract][Full Text] [Related]
18. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
Yarur AJ; Gondal B; Hirsch A; Christensen B; Cohen RD; Rubin DT
J Clin Gastroenterol; 2018 Jul; 52(6):537-544. PubMed ID: 28723860
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]